Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
Excavated with colonial labor and shipped to the Netherlands, the famous fossil is being repatriated to Indonesia along with 28,000 other fossils. The skull cap of 'Java Man' was discovered by Eugène ...
JDK 25 brings powerful new features to Java and JVM developers. Here are seven new or updated features that could convince you to switch. Java continues its fast and feature-packed release schedule, ...
BLOOMINGTON, Ind. (WISH) — Purdue University’s independent student newspaper, Purdue Exponent, stocked Indiana University’s Indiana Daily Student (IDS) newsstands in Bloomington over the weekend as a ...
After IU stopped the Indiana Daily Student from printing their news, the Purdue Exponent delivered a special edition to Bloomington. The special 'solidarity edition' contains columns from Exponent and ...
The offer values the company at around £173.8m The acquisition will be funded in part through equity from Exponent Fund IV and Exponent Fund V Exponent invested in Natara in 2023 Exponent Private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback